HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

tris(2,2-dimethyl-1-aziridinyl)phosphine oxide

an alkylating agent, , was chosen for clinical trial because of its superior performance in animal tumor systems
Also Known As:
TEPA-132
Networked: 0 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results